Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy progress and prospects: episomally maintained self-replicating systems.

M Conese1, C Auriche, F Ascenzioni

  • 1Institute for Experimental Treatment of Cystic Fibrosis, HS Raffaele, Milano, Italy.

Gene Therapy
|September 24, 2004
PubMed
Summary

Episomal gene therapy vectors show promise for overcoming low transfection efficiency and achieving sustained gene expression. This review covers EBV-based, S/MARs, and chromosomal vectors, highlighting their potential for stable gene delivery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanoparticle delivery of grape seed-derived proanthocyanidins to airway epithelial cells dampens oxidative stress and inflammation.

Journal of translational medicine·2018
Same author

Realization of polyaspartamide-based nanoparticles and in vivo lung biodistribution evaluation of a loaded glucocorticoid after aerosolization in mice.

International journal of pharmaceutics·2016
Same author

Adipose-derived mesenchymal stromal (stem) cells differentiate to osteoblast and chondroblast lineages upon incubation with conditioned media from dental pulp stem cell-derived osteoblasts and auricle cartilage chondrocytes.

Journal of biological regulators and homeostatic agents·2016
Same author

Adhesion and growth of osteoblast-like cells on laser-engineered porous titanium surface: expression and localization of N-cadherin and beta-catenin.

Journal of biological regulators and homeostatic agents·2013
Same author

Analysis of inflammatory and immune response biomarkers in sputum and exhaled breath condensate by a multi-parametric biochip array in cystic fibrosis.

International journal of immunopathology and pharmacology·2011
Same author

Reduction of tumor-associated fibrinolytic-activity by antimetastatic dosages of 2 ru(ii)-dmso complexes in mice bearing lewis lung-carcinoma.

International journal of oncology·2011

Area of Science:

  • Biotechnology
  • Gene Therapy
  • Molecular Biology

Background:

  • Nonviral gene therapy vectors often suffer from poor transfection efficiency and transient gene expression.
  • Episomal systems offer potential solutions due to their large capacity, stability, and reduced toxicity.

Purpose of the Study:

  • To review and evaluate different classes of episomal molecules for gene therapy applications.
  • To assess their efficacy in achieving stable and prolonged therapeutic gene expression.

Main Methods:

  • Review of studies utilizing three main types of episomal vectors: Epstein-Barr virus (EBV)-based self-replicating vectors, small circular vectors with scaffold/matrix attachment regions (S/MARs), and chromosomal vectors.
  • Analysis of data on transfection efficiency, gene expression stability, and vector-associated toxicity.

Related Experiment Videos

Main Results:

  • Episomal vectors demonstrate potential for stable and prolonged gene expression, addressing key limitations of traditional nonviral vectors.
  • Each vector class (EBV-based, S/MARs, chromosomal) shows specific advantages and limitations regarding therapeutic gene delivery.

Conclusions:

  • Episomal vectors represent a viable strategy for enhancing gene therapy outcomes by enabling sustained gene expression.
  • Further research is needed to optimize these episomal systems and overcome existing limitations for clinical translation.